期刊
CLINICAL INFECTIOUS DISEASES
卷 37, 期 12, 页码 1668-1677出版社
OXFORD UNIV PRESS INC
DOI: 10.1086/379775
关键词
-
Respiratory syncytial virus ( RSV) and human parainfluenza viruses ( hPIVs) are leading causes of viral lower respiratory tract illness in children and in high- risk adult populations. Despite decades of research, licensed vaccines for RSV and hPIVs do not exist. Recently, however, genetically engineered live attenuated RSV and hPIV candidate vaccines have been generated, several of which are already being evaluated in clinical trials. Recombinant technology allows candidate vaccines to be fine-tuned in response to clinical data, which should hasten the development of vaccines against these important respiratory pathogens.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据